Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
J Nutr Biochem ; 30: 116-25, 2016 Apr.
Article in English | MEDLINE | ID: mdl-27012628

ABSTRACT

In this study, we evaluated the protective effects of dietary walnuts on high-fat diet (HFD)-induced fatty liver and studied the underlying mechanisms. Male C57BL/6J mice were fed either a regular rodent chow or HFD (45% energy-derived) with or without walnuts (21.5% energy-derived) for 20weeks. Walnut supplementation did not change HFD-induced increase in body weight or visceral fat mass. However, dietary walnuts significantly decreased the amounts of hepatic triglyceride (TG) observed in HFD-fed mice. The addition of walnuts significantly altered the levels of proteins, involved in the hepatic lipid homeostasis, including AMP-activated protein kinase, fatty acid synthase and peroxisome proliferator-activated receptor-α. Since adipocyte inflammation and apoptosis are reportedly important in regulating hepatic fat accumulation, we also evaluated the protective effects of walnuts on adipose tissue injury. Real-time polymerase chain reaction results revealed that adipose tissues isolated from mice fed the HFD+walnut diets showed significantly decreased levels of macrophage infiltration with suppressed expression of proinflammatory genes compared to those significantly elevated in mice fed HFD alone. These improvements also coincided with reduction of HFD-induced apoptosis of adipocytes by dietary walnuts. However, the supplemented walnuts did not significantly alter HFD-induced peripheral glucose intolerance or insulin resistance despite a trend of improvement. Collectively, these results demonstrate that the protective effects of walnuts against HFD-induced hepatic TG accumulation in mice are mediated, at least partially, by modulating the key proteins in hepatic lipid homeostasis and suppression of the genes related to adipose tissue inflammation and macrophage infiltration as well as prevention of adipocyte apoptosis.


Subject(s)
Adipose Tissue/metabolism , Diet, High-Fat , Fatty Acids/metabolism , Inflammation/metabolism , Juglans , Liver/metabolism , Triglycerides/metabolism , Adipose Tissue/pathology , Animals , Inflammation/pathology , Mice
2.
Obesity (Silver Spring) ; 22(2): 408-17, 2014 Feb.
Article in English | MEDLINE | ID: mdl-23818423

ABSTRACT

OBJECTIVE: The aim of this study was to investigate the protective effects of camphene on high-fat diet (HFD)-induced hepatic steatosis and insulin resistance in mice and to elucidate its mechanism of action. DESIGN AND METHODS: Male C57BL/6N mice were fed with a normal diet, HFD (20% fat and 1% cholesterol of total diet), or HFD supplemented with 0.2% camphene (CPND) for 10 weeks. RESULTS: Camphene alleviated the HFD-induced increases in liver weight and hepatic lipid levels in mice. Camphene also increased circulating adiponectin levels. To examine the direct effects of camphene on adiponectin secretion, 3T3-L1 adipocytes were incubated with camphene. Consistent with in vivo result, camphene increased adiponectin expression and secretion in 3T3-L1 adipocytes. In HFD-fed mice, camphene increased hepatic adiponectin receptor expression and AMP-activated protein kinase (AMPK) activation. Concordant with the activation of adiponectin-AMPK signaling, camphene increased hepatic expression of fatty acid oxidation-related genes and decreased those of lipogenesis-related genes in HFD-fed mice. Moreover, camphene increased insulin-signaling molecules activation and stimulated glucose transporter-2translocation to the plasma membrane in the liver. CONCLUSIONS: These results suggest camphene prevents HFD-induced hepatic steatosis and insulin resistance in mice; furthermore, these protective effects are mediated via the activation of adiponectin-AMPK signaling.


Subject(s)
AMP-Activated Protein Kinases/metabolism , Adiponectin/agonists , Dietary Supplements , Fatty Liver/prevention & control , Insulin Resistance , Liver/metabolism , Terpenes/therapeutic use , 3T3-L1 Cells , AMP-Activated Protein Kinases/chemistry , Adipocytes, White/metabolism , Adipocytes, White/pathology , Adipogenesis , Adiponectin/genetics , Adiponectin/metabolism , Animals , Antioxidants/metabolism , Antioxidants/therapeutic use , Bicyclic Monoterpenes , Enzyme Activation , Fatty Liver/metabolism , Fatty Liver/pathology , Fatty Liver/physiopathology , Gene Expression Regulation , Liver/pathology , Liver/physiopathology , Male , Mice , Mice, Inbred C57BL , Organ Size , Random Allocation , Receptors, Adiponectin/agonists , Receptors, Adiponectin/genetics , Receptors, Adiponectin/metabolism , Signal Transduction , Terpenes/metabolism
3.
Food Chem ; 141(4): 3627-35, 2013 Dec 15.
Article in English | MEDLINE | ID: mdl-23993530

ABSTRACT

This study examined the effect of piperine on hepatic steatosis and insulin resistance induced in mice by feeding a high-fat diet (HFD) for 13 weeks and elucidated potential underlying molecular mechanisms. Administration of piperine (50 mg/kg body weight) to mice with HFD-induced hepatic steatosis resulted in a significant increase in plasma adiponectin levels. Also, elevated plasma concentrations of insulin and glucose and hepatic lipid levels induced by feeding a HFD were reversed in mice when they were administered piperine. However, piperine did not reduce body weight and other biochemical markers to an extent where they became equal to the levels found in the CD-fed mice. Piperine reversed HFD-induced down-regulation of adiponecitn-AMP-activated protein kinase (AMPK) signalling molecules which play an important role in mediating lipogenesis, fatty acid oxidation and insulin signalling in the livers of mice. The expressions of lipogenic target genes were decreased, whereas the expression of carnitine palmitoyltransferase 1 (CPT1) gene involved in fatty acid oxidation was increased in the livers of the Pin50 group. Piperine significantly decreased the phosphorylation of insulin receptor substrate-1 (IRS-1) compared with the HFD-fed mice. Administration of piperine appeared to reverse preexisting HFD-induced hepatic steatosis and insulin resistance, probably by activation of adiponectin-AMPK signalling in mice.


Subject(s)
Alkaloids/administration & dosage , Benzodioxoles/administration & dosage , Fatty Liver/drug therapy , Fatty Liver/metabolism , Insulin Resistance , Piper nigrum/chemistry , Piperidines/administration & dosage , Plant Extracts/administration & dosage , Polyunsaturated Alkamides/administration & dosage , AMP-Activated Protein Kinases/metabolism , Adiponectin/metabolism , Animals , Diet, High-Fat/adverse effects , Humans , Lipogenesis/drug effects , Male , Mice , Mice, Inbred C57BL , Triglycerides/metabolism
4.
Article in English | MEDLINE | ID: mdl-23533470

ABSTRACT

We investigated the protective effect of carvacrol against high-fat-diet-induced hepatic steatosis in mice and the potential underlying molecular mechanisms. Mice were fed a normal diet, high-fat diet, or carvacrol-supplemented high-fat diet for 10 weeks. Compared to mice fed the high-fat diet, those fed the carvacrol-supplemented diet showed significantly lower hepatic lipid levels and reduced plasma activities of alanine aminotransferase and aspartate aminotransferase and plasma concentrations of monocyte chemoattractant protein 1 and tumor necrosis factor α . Carvacrol decreased the expression of LXR α , SREBP1c, FAS, leptin, and CD36 genes and phosphorylation of S6 kinase 1 protein involved in lipogenesis, whereas it increased the expression of SIRT1 and CPT1 genes and phosphorylation of liver kinase B1, AMP-activated protein kinase, and acetyl-CoA carboxylase proteins involved in fatty acid oxidation in the liver of mice fed the high-fat diet. These results suggest that carvacrol prevents HFD-induced hepatic steatosis by activating SIRT1-AMPK signaling.

5.
J Nutr Biochem ; 23(12): 1732-9, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22569347

ABSTRACT

Indole-3-carbinol (I3C) is a compound found in high concentrations in Brassica family vegetables, including broccoli, cauliflower and cabbage, and is regarded as a promising chemopreventive agent against various cancers. This study assesses the protective effect of I3C against diet-induced obesity in mice. Mice were randomly grouped to receive either a normal diet, high-fat (40% energy as fat) diet (HFD) or I3C-supplemented diet (1 g/kg diet) for 10 weeks. I3C supplementation significantly ameliorated HFD-induced increases in body weight gain, visceral fat pad weights and plasma lipid levels. The visceral adipose tissue mRNA levels of uncoupling proteins 1 and 3, crucial factors of thermogenesis, and their regulators such as sirtuin 1, peroxisome proliferator-activated receptor (PPAR) α and PPARγ coactivator 1α, which were down-regulated by HFD, were normalized by supplementation with I3C. In contrast, I3C supplementation significantly decreased expression levels of a key adipogenic transcription factor, PPARγ2, and its target genes, such as leptin and adipocyte protein 2, in the visceral adipose tissue of mice maintained on the HFD. Furthermore, HFD-induced up-regulation in mRNA levels of inflammatory cytokines (tumor necrosis factor α, interferon ß and interleukin 6) was significantly ameliorated by I3C. These findings suggest that I3C has a potential benefit in preventing obesity and metabolic disorders, and the action for I3C in vivo may involve multiple mechanisms including decreased adipogenesis and inflammation, along with activated thermogenesis.


Subject(s)
Adipogenesis/genetics , Anti-Obesity Agents/pharmacology , Gene Expression Regulation/drug effects , Indoles/pharmacology , Inflammation/genetics , Intra-Abdominal Fat/drug effects , Obesity/prevention & control , Thermogenesis/genetics , 3T3-L1 Cells/drug effects , Adipogenesis/drug effects , Adipose Tissue/drug effects , Animals , Cell Differentiation/drug effects , Diet, High-Fat/adverse effects , Dietary Supplements , Intra-Abdominal Fat/metabolism , Lipids/blood , Male , Mice , Mice, Inbred C57BL , Obesity/etiology , Obesity/genetics , Thermogenesis/drug effects
6.
J Biomed Biotechnol ; 2012: 141395, 2012.
Article in English | MEDLINE | ID: mdl-22013387

ABSTRACT

This study evaluated the antilipogenic and anti-inflammatory effects of Codonopsis lanceolata (C. lanceolata) root extract in mice with alcohol-induced fatty liver and elucidated its underlying molecular mechanisms. Ethanol was introduced into the liquid diet by mixing it with distilled water at 5% (wt/v), providing 36% of the energy, for nine weeks. Among the three different fractions prepared from the C. lanceolata root, the C. lanceolata methanol extract (CME) exhibited the most remarkable attenuation of alcohol-induced fatty liver with respect to various parameters such as hepatic free fatty acid concentration, body weight loss, and hepatic accumulations of triglyceride and cholesterol. The hepatic gene and protein expression levels were analysed via RT-PCR and Western blotting, respectively. CME feeding significantly restored the ethanol-induced downregulation of the adiponectin receptor (adipoR) 1 and of adipoR2, along with their downstream molecules. Furthermore, the study data showed that CME feeding dramatically reversed ethanol-induced hepatic upregulation of toll-like receptor- (TLR-) mediated signaling cascade molecules. These results indicate that the beneficial effects of CME against alcoholic fatty livers of mice appear to be with adenosine- and adiponectin-mediated regulation of hepatic steatosis and TLR-mediated modulation of hepatic proinflammatory responses.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Codonopsis/chemistry , Fatty Liver, Alcoholic/prevention & control , Lipid Regulating Agents/administration & dosage , Plant Extracts/administration & dosage , Adenosine/genetics , Adenosine/metabolism , Animals , Cholesterol/metabolism , Disease Models, Animal , Ethanol/toxicity , Gene Expression Regulation/drug effects , Liver/drug effects , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Receptors, Adiponectin/genetics , Receptors, Adiponectin/metabolism , Signal Transduction/drug effects , Toll-Like Receptors/genetics , Toll-Like Receptors/metabolism , Triglycerides/metabolism
7.
Arch Biochem Biophys ; 476(2): 178-85, 2008 Aug 15.
Article in English | MEDLINE | ID: mdl-18314006

ABSTRACT

The aim of present study was to investigate the anti-obesity effect of Ilex paraguariensis extract and its molecular mechanism in rats rendered obese by a high-fat diet (HFD). I. paraguariensis extract supplementation significantly lowered body weight, visceral fat-pad weights, blood and hepatic lipid, glucose, insulin, and leptin levels of rats administered HFD. Feeding I. paraguariensis extract reversed the HFD-induced downregulation of the epididymal adipose tissue genes implicated in adipogenesis or thermogenesis, such as peroxisome proliferators' activated receptor gamma2, adipocyte fatty acid binding protein, sterol-regulatory-element-binding protein-1c, fatty acid synthase, HMG-CoA reductase, uncoupling protein 2, and uncoupling protein 3. Dietary supplementation with I. paraguariensis extract protected rats from the HFD-induced decreases in the phospho-AMP-activated protein kinase (AMPK)/AMPK and phospho-acetyl-CoA carboxylase (ACC)/ACC protein ratio related to fatty acid oxidation in the edipidymal adipose tissue. The present study reports that the I. paraguariensis extract can have a protective effect against a HFD-induced obesity in rats through an enhanced expression of uncoupling proteins and elevated AMPK phosphorylation in the visceral adipose tissue.


Subject(s)
Adenylate Kinase/metabolism , Dietary Fats/administration & dosage , Ilex paraguariensis , Intra-Abdominal Fat/drug effects , Obesity/drug therapy , Plant Extracts/pharmacology , Animals , Male , Rats , Rats, Sprague-Dawley
SELECTION OF CITATIONS
SEARCH DETAIL